NHS mergers reviews

Clarifies CMA’s role in the review of mergers between NHS foundation trusts and NHS trusts.

This publication was withdrawn on

This document has been superseded by Review of NHS mergers: CMA29.


The OFT's role in reviewing NHS mergers: FAQ

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This guidance was originally published by the Office of Fair Trading (OFT) and has been adopted by the CMA Board. The original text has been retained unamended, therefore it does not reflect or take account of developments in case law, legislation or practice since its original publication.

Please also note:

  • all references to issues of jurisdiction or procedure in mergers cases must be read in the light of Mergers: Guidance on the CMA’s jurisdiction and procedure (CMA2); in the case of conflict, CMA2 prevails
  • references to the OFT or CC (except where referring to specific past OFT or CC practice or case law) should be read as referring to the CMA
  • references to ‘referral to the CC’ or ‘a reference to the CC’ should be read as the referral of a case by the CMA (or Secretary of State) for a Phase 2 investigation involving an Inquiry Group of CMA panel members
  • references to articles of the EC Treaty should be read as referring to the equivalent articles of the Treaty on the Functioning of the European Union
  • certain OFT or CC departments, teams or individual roles may not be replicated in the CMA, or may have been renamed; the CMA’s structure is set out in our organisation chart
  • do not use any contact details quoted; please go to the home page for details on how to contact the CMA
Published 12 March 2014